PTEN in Hematopoietic and Intestinal Stem Cells and Cancer

作者: Jason T. Ross , David H. Scoville , Xi He , Linheng Li

DOI: 10.1007/978-1-60327-933-8_5

关键词:

摘要: In this chapter, we discuss the roles of tumor suppressor PTEN in regulating stem cells hematopoietic and intestinal systems as well its contributions to carcinogenesis these tissues. Stem continually renewing tissues must balance necessity maintain their respective tissue with requirement preserve cell pool throughout adult life. Hematopoietic (HSCs) are tasked sustaining various types blood while regenerate gut epithelium. PTEN, a dual-specificity phosphatase able target proteins lipids, is sole antagonist PI3K/AKT signaling pathway. often activated by growth factors typically results stimulation cellular outcomes such proliferation, inhibition apoptosis, migration. Functional studies loss animal models have indicated role for protective agent that promote quiescence, PTEN-deficient animals exhibit overproliferative progenitor prone proliferative disorders cancer development. However, from other including accumulated clinical evidence, it not likely acts alone stimulate malignant transformation. Indeed, HSCs become exhausted unable sustain healthy system. Rather, appears function restrictive factor prevents unregulated which leaves susceptible additional mutations/deregulation, Wnt/β-catenin signaling, overt cancer. Additional study into PTEN/PI3K/AKT should provide further insight self-renewal mechanisms may aid distinguishing normal cancer-initiating counterparts.

参考文章(94)
RA Shivdasani, SH Orkin, The transcriptional control of hematopoiesis. Blood. ,vol. 87, pp. 4025- 4039 ,(1996) , 10.1182/BLOOD.V87.10.4025.BLOODJOURNAL87104025
Akira Sakai, Catherine Thieblemont, Axel Wellmann, Elaine S. Jaffe, Mark Raffeld, PTEN Gene Alterations in Lymphoid Neoplasms Blood. ,vol. 92, pp. 3410- 3415 ,(1998) , 10.1182/BLOOD.V92.9.3410
Kateri A. Moore, Hideo Ema, Ihor R. Lemischka, In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood. ,vol. 89, pp. 4337- 4347 ,(1997) , 10.1182/BLOOD.V89.12.4337
David Stokoe, Lawrence P. Kane, Arthur Weiss, Zheng Xu, The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. Cell Growth & Differentiation. ,vol. 13, pp. 285- 296 ,(2002)
Harry W. Findley, Lubing Gu, William G. Woods, Muxiang Zhou, Rong Jiang, PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells. Cancer Research. ,vol. 63, pp. 6357- 6362 ,(2003)
Marian S. Blazes, Kathleen R. Cho, Steven I. Wang, Ramon Parsons, Shikha Bose, Lora Hedrick Ellenson, Hironori Tashiro, Jing Li, Rong Wu, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Research. ,vol. 57, pp. 3935- 3940 ,(1997)
Andrew Berchuck, John I. Risinger, J. Carl Barrett, A. Kate Hayes, PTEN/MMAC1 Mutations in Endometrial Cancers Cancer Research. ,vol. 57, pp. 4736- 4738 ,(1997)
Ting Xie, Allan C Spradling, A Niche Maintaining Germ Line Stem Cells in the Drosophila Ovary Science. ,vol. 290, pp. 328- 330 ,(2000) , 10.1126/SCIENCE.290.5490.328
Faina Bogomolniy, Esther Rhei, Patrick I. Borgen, Lan Kang, Mark G. Federici, Jeff Boyd, Mutation Analysis of the Putative Tumor Suppressor Gene PTEN/MMAC1 in Primary Breast Carcinomas Cancer Research. ,vol. 57, pp. 3657- 3659 ,(1997)
Mark J. Bitgood, Andrew P. McMahon, HedgehogandBmpGenes Are Coexpressed at Many Diverse Sites of Cell–Cell Interaction in the Mouse Embryo Developmental Biology. ,vol. 172, pp. 126- 138 ,(1995) , 10.1006/DBIO.1995.0010